3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
3
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Radiation-induced Injuries in Patients With Rectal Cancer
1
Radiation Injuries
1
Precancerous Conditions
1
Neoplasms, Second Primary
1
Neoplasms
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Head and Neck Fibrosis
1
Fibrosis
1
Erectile Dysfunction
1
Colorectal Neoplasms
1
Adenomatous Polyps
1
Interventions
Peripheral Blood Stem Cell Transplantation
9
Cyclophosphamide
9
Biopsy
8
fludarabine phosphate
7
Whole-Body Irradiation
6
Tacrolimus
5
Mycophenolic Acid
5
Epoetin Alfa
5
Colposcopy
5
Celecoxib
5
Busulfan
5
Aminolevulinic Acid
5
Sulindac
4
Selenium
4
Methotrexate
4
Melphalan
4
Cyclosporine
4
Cetuximab
4
Antilymphocyte Serum
4
Polymerase Chain Reaction
3
Imiquimod
3
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
Gene Expression Profiling
3
Etoposide
3
Eflornithine
3
Darbepoetin alfa
3
Carboplatin
3
Aspirin
3
fludarabine
2
Watchful Waiting
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Precancerous Conditions
×
alpha-Tocopherol
×
Clear all
NCT00706121
2019-12-16
ACP
SWOG Cancer Research Network
Phase 3
Completed
8,094 enrolled
23 charts